JP2024539079A5 - - Google Patents
Info
- Publication number
- JP2024539079A5 JP2024539079A5 JP2024523266A JP2024523266A JP2024539079A5 JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5 JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024523266 A JP2024523266 A JP 2024523266A JP 2024539079 A5 JP2024539079 A5 JP 2024539079A5
- Authority
- JP
- Japan
- Prior art keywords
- binding molecule
- sequence
- amino acid
- nucleic acid
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2114938.0A GB202114938D0 (en) | 2021-10-19 | 2021-10-19 | Her2 variant car |
| GB2114938.0 | 2021-10-19 | ||
| PCT/EP2022/079110 WO2023067007A1 (en) | 2021-10-19 | 2022-10-19 | Her2 variant car |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539079A JP2024539079A (ja) | 2024-10-28 |
| JP2024539079A5 true JP2024539079A5 (enExample) | 2025-10-10 |
Family
ID=78718395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523266A Pending JP2024539079A (ja) | 2021-10-19 | 2022-10-19 | Ｈｅｒ２バリアントｃａｒ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240398949A1 (enExample) |
| EP (1) | EP4419133A1 (enExample) |
| JP (1) | JP2024539079A (enExample) |
| KR (1) | KR20240099303A (enExample) |
| CN (1) | CN118382455A (enExample) |
| GB (1) | GB202114938D0 (enExample) |
| WO (1) | WO2023067007A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025147472A1 (en) * | 2024-01-02 | 2025-07-10 | Phanes Therapeutics, Inc. | Anti-611-ctf p95her2 antibodies and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2342646B1 (es) * | 2008-06-02 | 2011-04-26 | Institut De Recerca Hospital Universitari Vall Hebron | Metodo de diagnostico de canceres que expresan el receptor her-2 o sus variantes truncadas. |
| EP2438442B1 (en) * | 2008-12-01 | 2017-08-09 | Laboratory Corporation of America Holdings | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 |
| JP5972871B2 (ja) * | 2010-07-20 | 2016-08-17 | テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド | 抗ｉｌ−２３ヘテロ二量体特異的抗体 |
| WO2020075325A1 (ja) * | 2018-10-09 | 2020-04-16 | 公立大学法人福島県立医科大学 | 子宮体癌患者の予後予測バイオマーカー |
| EP3915576A1 (en) * | 2020-05-28 | 2021-12-01 | Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron | Chimeric antigen receptors specific for p95her2 and uses thereof |
| AU2023282410A1 (en) * | 2022-06-07 | 2024-12-05 | Duality Biologics (Suzhou) Co., Ltd. | Anti-b7h3 antibody-drug conjugate and use thereof |
-
2021
- 2021-10-19 GB GBGB2114938.0A patent/GB202114938D0/en not_active Ceased
-
2022
- 2022-10-19 WO PCT/EP2022/079110 patent/WO2023067007A1/en not_active Ceased
- 2022-10-19 KR KR1020247016436A patent/KR20240099303A/ko active Pending
- 2022-10-19 EP EP22808985.0A patent/EP4419133A1/en active Pending
- 2022-10-19 JP JP2024523266A patent/JP2024539079A/ja active Pending
- 2022-10-19 US US18/698,327 patent/US20240398949A1/en active Pending
- 2022-10-19 CN CN202280081682.6A patent/CN118382455A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7295146B2 (ja) | 抗－ｒｏｒ１抗体およびその用途 | |
| JP7000660B2 (ja) | Ｒｏｒ１抗体組成物及び関連の方法 | |
| CN109843927B (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| JP2026001061A (ja) | 抗ｄｌｌ３キメラ抗原受容体及びその使用 | |
| JP6606505B2 (ja) | 抗ＳＩＲＰα抗体および二重特異性マクロファージ増強抗体 | |
| JP7820383B2 (ja) | グリピカン－３およびｔ細胞受容体を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド | |
| JP2021526816A (ja) | Ｄｌｌ３−ｃｄ３二重特異性抗体 | |
| JP2021524746A (ja) | 抗−ｂ７−ｈ３抗体およびその用途 | |
| JP2019116474A5 (enExample) | ||
| JP2020525032A5 (enExample) | ||
| CA3196809A1 (en) | Combination treatment | |
| JP2022542543A5 (enExample) | ||
| AU2018218753A1 (en) | Anti-GPRC5D antibody and molecule containing same | |
| JP2024001073A5 (enExample) | ||
| JP2018532383A5 (enExample) | ||
| JP2019527553A5 (enExample) | ||
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| JP2019513370A5 (enExample) | ||
| KR20220012313A (ko) | 항-ror1/항-cd3 이중특이적 결합 분자 | |
| JP7821159B2 (ja) | Ｂｃｍａと結合する単一可変ドメイン及び抗原結合分子 | |
| EP3405494A1 (en) | Ror2 antibody compositions and related methods | |
| WO2017072366A1 (en) | Anti-mesothelin antibodies | |
| JP2021521793A5 (enExample) | ||
| CN108948194B (zh) | 一种新的ctla-4单克隆抗体 | |
| JP2018522888A5 (enExample) |